- ¥62bn
- ¥46bn
- ¥600bn
- 42
- 90
- 37
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.57 | ||
| Price to Tang. Book | 0.6 | ||
| Price to Free Cashflow | 25.47 | ||
| Price to Sales | 0.1 | ||
| EV to EBITDA | 5.98 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.16% | ||
| Return on Equity | 9.1% | ||
| Operating Margin | 0.66% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 537,030 | 577,249 | 579,772 | 587,481 | 600,370 | n/a | n/a | 1.31% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -64.12 | +229.06 | +19.55 | +0.64 | +28.85 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vital Ksk Holdings Inc is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments, including pharmaceutical wholesale, pharmacy, veterinary medicine wholesale, pharmaceuticals, and nursing care rental and other businesses. Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment and materials to hospitals, clinics and pharmacies. Pharmacy segment sells pharmaceuticals, medical equipment, instruments and sanitary materials to general consumers. Veterinary Medicine Wholesale segment sells veterinary medicines and feed to farms, ranches, veterinary hospitals and clinics. Nursing Care Rental and Other segment provides nursing care related services, wholesale of pesticides, transportation, sports facility management and consulting services to medical institutions. The Company also provides non-life insurance agency services, real estate brokerage and parking lot operations.
Directors
- Ken Suzuki CHM (73)
- Taisuke Murai PRE (67)
- Tamotsu Hattori VPR (65)
- Hiroyuki Chihara EDR (69)
- Hiroshi Ichijo EDR (62)
- Takeshi Ichijo EDR (61)
- Hiroshi Kitanaka EDR
- Shigeru Kobayashi EDR (60)
- Masao Tsukoshi EDR
- Tadaaki Uemura EDR
- Haruo Yamaki EDR
- Takenori Yoda EDR
- Nobuyuki Ohkuni OTH
- Hidetaro Matsui DRC
- Motoyasu Ohno DRC (53)
- Masaaki Manabe IND (79)
- Yasuaki Yoshimura IND (63)
- Last Annual
- March 31st, 2025
- Last Interim
- September 30th, 2025
- Incorporated
- April 1st, 2009
- Public Since
- April 1st, 2009
- No. of Shareholders
- 4,042
- No. of Employees
- 3,756
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 48,377,092
- Address
- 1-1-12, Tsurumaki, SETAGAYA-KU, 154-0016
- Web
- https://www.vitalksk.co.jp/
- Phone
- +81 357878550
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 3151
Dividend For 3151.T - 34.0000 JPY
Similar to 3151
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Vital Ksk Holdings share price?
As of Today at 23:01 UTC, shares in Vital Ksk Holdings are trading at ¥1,286. This share price information is delayed by 15 minutes.
How has the Vital Ksk Holdings share price performed this year?
Shares in Vital Ksk Holdings last closed at ¥1,286 and the price had moved by +9.35% over the past 365 days. In terms of relative price strength the Vital Ksk Holdings share price has underperformed the Nikkei 225 Index by -14.48% over the past year.
What are the analyst and broker recommendations for Vital Ksk Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Vital Ksk Holdings dividend yield?
The Vital Ksk Holdings dividend yield is 4.51% based on the trailing twelve month period.
Does Vital Ksk Holdings pay a dividend?
Last year, Vital Ksk Holdings paid a total dividend of ¥58, and it currently has a trailing dividend yield of 4.51%.Looking ahead, shares in Vital Ksk Holdings are due to go ex-dividend on 2026-03-30 and the next dividend pay date is 2025-12-03.
When does Vital Ksk Holdings next pay dividends?
Vital Ksk Holdings are due to go ex-dividend on 2026-03-30 and the next dividend pay date is 2025-12-03. The historic dividend yield on Vital Ksk Holdings shares is currently 4.51%.
How do I buy Vital Ksk Holdings shares?
To buy shares in Vital Ksk Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vital Ksk Holdings?
As of the previous close price of ¥1,286, shares in Vital Ksk Holdings had a market capitalisation of ¥62bn.
Where are Vital Ksk Holdings shares listed?
Here are the trading details for Vital Ksk Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 3151
What kind of share is Vital Ksk Holdings?
Based on an overall assessment of its quality, value and momentum Vital Ksk Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vital Ksk Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Vital Ksk Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vital Ksk Holdings. Over the past six months, its share price has underperformed the Nikkei 225 Index by -20.08%.
As of the last closing price of ¥1,286, shares in Vital Ksk Holdings were trading +2.87% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vital Ksk Holdings PE Ratio?
The Vital Ksk Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,286.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vital Ksk Holdings?
Vital Ksk Holdings' management team is headed by:
- Ken Suzuki - CHM
- Taisuke Murai - PRE
- Tamotsu Hattori - VPR
- Hiroyuki Chihara - EDR
- Hiroshi Ichijo - EDR
- Takeshi Ichijo - EDR
- Hiroshi Kitanaka - EDR
- Shigeru Kobayashi - EDR
- Masao Tsukoshi - EDR
- Tadaaki Uemura - EDR
- Haruo Yamaki - EDR
- Takenori Yoda - EDR
- Nobuyuki Ohkuni - OTH
- Hidetaro Matsui - DRC
- Motoyasu Ohno - DRC
- Masaaki Manabe - IND
- Yasuaki Yoshimura - IND